THYMIC CARCINOMA
Clinical trials for THYMIC CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new THYMIC CARCINOMA trials appear
Sign up with your email to follow new studies for THYMIC CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heated chemo plus surgery shows promise for rare chest cancer spread
Disease control Not yet recruitingThis study looks at whether a combination of surgery to remove tumor spots from the chest lining followed by heated chemotherapy can help people with a rare thymus gland tumor that has spread. About 70 adults aged 16 to 80 will take part. The goal is to see if this approach delay…
Matched conditions: THYMIC CARCINOMA
Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated May 17, 2026 09:09 UTC
-
New drug combo aims to shrink Hard-to-Treat thymic tumors before surgery
Disease control Not yet recruitingThis phase II trial tests whether adding the immunotherapy drug adebrelimab to standard chemotherapy and radiation before surgery can shrink tumors in people with locally advanced thymic carcinoma. About 31 participants will receive 2-4 cycles of this combination, then have surge…
Matched conditions: THYMIC CARCINOMA
Phase: PHASE2 • Sponsor: Shanghai Chest Hospital • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New drug hope for rare thymic cancer after chemotherapy fails
Disease control Not yet recruitingThis study tests a drug called Sac-TMT in 30 people with advanced thymic carcinoma that has worsened after platinum-based chemotherapy. The goal is to see if the drug can shrink tumors and how safe it is. Participants receive the drug every two weeks and have scans every six week…
Matched conditions: THYMIC CARCINOMA
Phase: PHASE2 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 05, 2026 11:56 UTC